Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;83(1):e11-e13.
doi: 10.1016/j.jinf.2021.05.011. Epub 2021 May 21.

Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?

Affiliations
Comment

Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?

Md Jahidul Hasan et al. J Infect. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Comment on

References

    1. Tharmarajah E., Buazon A., Patel V., Hannah J.R., Adas M., Allen V.B. IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression. J Infect. 2021;82(5):178–185. doi: 10.1016/j.jinf.2021.03.008. - DOI - PMC - PubMed
    1. Pelaia C., Calabrese C., Garofalo E., Bruni A., Vatrella A., Pelaia G. Therapeutic role of tocilizumab in SARS-CoV-2-induced cytokine storm: rationale and current evidence. Int J Mol Sci. 2021;22(6):3059. doi: 10.3390/ijms22063059. - DOI - PMC - PubMed
    1. Attaway A.H., Scheraga R.G., Bhimraj A., Biehl M., Hatipoğlu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021;372:n436. doi: 10.1136/bmj.n436. - DOI - PubMed
    1. Hasan M.J., Rabbani R., Anam A.M., Huq S.M.R. Additional baricitinib loading dose improves clinical outcome in COVID-19. Open Med. 2020;16(1):41–46. doi: 10.1515/med-2021-0010. - DOI - PMC - PubMed
    1. Hasan M J. Tocilizumab in COVID-19 treatment: a cost-burden in low- and middle-income countries. Int J Health Life Sci. 2000;6(2) doi: 10.5812/ijhls.104480. - DOI